Geller JL, Adams JS. Vitamin D Therapy. Current Osteoporosis Reports 2008
Cooper OB, Geller JL and Melmed S. Ovarian Hyperstimulation Syndrome caused by an FSH-Secreting Pituitary Adenoma. Nat Clin Pract Endocrinol Metab. Feb 12, 2008
Geller JL, Hu B, Reed S, Mirocha J and Adams JS.Increase in Bone Mass After Correction of Vitamin D Insufficiency in Bisphosphonate-Treated Patients Endo Prac. 2008; 14:3
Geller JL Vitamin D: The Sunshine Hormone. Food Technology, June 2007
Geller JL, Adams, JS. Proton Pump Inhibitor Therapy and Hip Fracture Risk. JAMA. 2007; 297:1429
Geller JL, Azarmindokht K, Kelly MH, et al. Clinical Vignette: Cinacalcet in the Management of Tumor-Induced Osteomalacia. J Bone Min Res. 2007; Mar 12
Geller JL The Way I see it: Healthcare Reform Begins with Patients. Medical Economics. Dec 15, 2006
Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JA, Hewison M, Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: further evidence for extra-renal expression of 25-hydroxyvitamin D-1α-hydroxylase in granulomatous disorders. J Bone Min Res. 2006 Sep; 1496-9
Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented Adrenocortical Carcinoma: case report and review. Endocr Pathol. 2006; 17: 297-304.
Geller JL, Braunstein GB. Dermatological Manifestations of Hypopituitarism. Clinics in Dermatology. 2006; 42:266-275.
Geller JL. Borrowing Against the Bones: The Price of Eucalcemia. Nutrition and the M.D. 2006; 32:5
Geller JL, Adams JS. Statins and Fracture: All Variables Accounted For? Archives of Internal Medicine 2006; 166:1041
Geller JL, Arteaga V, Fan X, Yu J. A Symptomatic Prolactinoma Co-existing within a Rathke’s Cleft Cyst Invading Bone: Case Report and Review. The Endocrinologist 2006;91-94.
Geller, JL, Mertens, RB and Weiss LM. Adrenocortical Carcinoma: Many Questions Remain Unanswered. The Endocrinologist, 2005; 15: 309-312.
Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. Journal of Clinical Gastroenterology, 2006; 40:55-63.
Geller JL, Hackner D. Prolonged Refractory Streptococcal Toxic Shock Syndrome Complicoemboli: Case Report and Review. Annals of Hematology. 2005 Apr 7
Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta S. Clinical Science Color Atlas. Blackwell, 2002
